ArticleHernia : the journal of hernias and abdominal wall surgery2026
Validation of a novel hernia recurrence grading classification system: a surgeon survey using clinical vignettes.
Article in Hernia : the journal of hernias and abdominal wall surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHernia recurrence following ventral hernia repair (VHR) is the primary outcome reported across the hernia surgery literature, yet it has historically been described as a binary, dichotomous variable - present or absent - without accounting for its clinical severity, symptom burden, or impact on quality of life. Our group previously published a novel grading classification for hernia recurrence (Grades 0 through VI) designed to standardize the nomenclature and provide a clinically meaningful framework for evaluating recurrence after VHR. To advance this classification toward widespread use, external validation is essential.
methodsWe designed a web-based survey instrument consisting of 26 standardized clinical vignettes, each constructed to correspond to a single, unambiguous grade within the Hernia Recurrence Grading System. Respondents were asked to assign the most appropriate grade (0, IA, IB, IIA, IIB, III, IV, V, or VI) to each scenario. The survey was distributed to practicing abdomninal wall surgery specialists. A total of 39 respondents completed the survey. Accuracy was defined as agreement with the a priori correct classification grade for each vignette, and overall concordance rates were calculated.
resultsThirty-nine respondents completed the survey, generating 1,014 individual responses across 26 vignettes. The overall concordance rate was 90.5% (918/1,014), with a mean per-vignette accuracy of 90.5% (median 93.6%; range 53.8%-100.0%). Fleiss' kappa was 0.815, indicating almost perfect inter-rater agreement. Three vignettes achieved 100% accuracy, and seventeen of twenty-six (65.4%) met a 90% concordance threshold. The highest grade-level accuracy was observed for Grades IV (97.4%), 0 (96.6%), IIB (96.6%), and III (95.7%). The lowest mean grade-level accuracy was Grade IB (73.5%), driven by a single outlier vignette (53.8%). The predominant misclassification patterns involved adjacent-grade confusion between Grades IB and IIA (21 errors) and between Grades IIA and IIB (16 errors).
conclusionsThis surgeon survey using standardized clinical vignettes provides initial evidence supporting the usability and inter-rater comprehensibility of the Hernia Recurrence Grading System. These findings represent an important step toward prospective multicenter validation of the classification and its integration into hernia registry reporting and clinical trial outcome definitions.
Indexed as
Identifiers
42714665What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.